IFIH1 and dermatomyositis: We found structural changes in the IIM subtypes after SARS-CoV-2 infection, with a lower proportion of patients with dermatomyositis and anti-MDA5-positive dermatomyositis and a greater proportion of patients with ASS and unclassified IIMs.